Table 6.

Lymphocyte subpopulation results in patients with CVID at diagnosis

Patient	CD3+ (%/μl)	CD3+CD4+ (%/μl)	CD3+CD8+ (%/μl)	CD 19+ (%/μl)
1	70.05/855	51.02/623	23/281	8.39/101
2	78.1/1464	52.30/981	23.60/443	10.7/201
3	77.21/3.62	17.52/0.82	57.57/2.7	0.3/0.01
4	72.3/1196	35.6/589	29.3/485	9/149
5	73.3/344	32.8/154	38.5/181	5.6/26
6	74.9/2902	21.5/833	45.6/1767	22.3/864
7	69.09/1350	41.2/806	20.19/393	18.98/370
8	68.3/848	35.1/436	26.8/333	19.90/350
9	84.1/6731	31.4/2513	50.6/4050	12.4/992
10	78.9/1515	15.8/303	49.8/956	5.9/113
11	53.17/994	14.67/273	36.3/680	6.87/127
12	71.97/1326	40.30/743	29.76/548	8.23/151
13	75.7/978	36.1/466	37.2/481	16.2/209
14	72.5/2208	25.5/777	35.3/1075	5.4/164
Min.	53.17/3.62	14.7/0.82	20.19/2.7	0.3/0.01
Max.	84.1/6731	52.3/2513	57.57/4050	22.3/992
Mean	72.8/1622.47	32.2/678	35.9/834	10.72/272.6
Median	72.9/1261	33.95/606	35.8/483	8.7/157.5
SD	7.089/1634.063	12.06/599	11.4/1025	6.4/296.8